[go: up one dir, main page]

MX340574B - Imidazo pirazinas. - Google Patents

Imidazo pirazinas.

Info

Publication number
MX340574B
MX340574B MX2013010183A MX2013010183A MX340574B MX 340574 B MX340574 B MX 340574B MX 2013010183 A MX2013010183 A MX 2013010183A MX 2013010183 A MX2013010183 A MX 2013010183A MX 340574 B MX340574 B MX 340574B
Authority
MX
Mexico
Prior art keywords
pyrazines
imidazo
compounds
pharmaceutically acceptable
pharmaceutical compositions
Prior art date
Application number
MX2013010183A
Other languages
English (en)
Other versions
MX2013010183A (es
Inventor
Thomas Luk Kin-Chun
Soth Michael
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2013010183A publication Critical patent/MX2013010183A/es
Publication of MX340574B publication Critical patent/MX340574B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se proporcionan los compuestos de la fórmula (ver Fórmula) y sus sales farmacéuticas aceptables se describen, así como las composiciones farmacéuticas que contienen dichos compuestos y sus sales farmacéuticas aceptables, y el uso de dichos compuestos y composiciones farmacéuticas para el tratamiento, control o mejora de AML.
MX2013010183A 2011-03-17 2012-03-14 Imidazo pirazinas. MX340574B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161453601P 2011-03-17 2011-03-17
PCT/EP2012/054415 WO2012123470A1 (en) 2011-03-17 2012-03-14 Imidazo pyrazines

Publications (2)

Publication Number Publication Date
MX2013010183A MX2013010183A (es) 2013-10-03
MX340574B true MX340574B (es) 2016-07-13

Family

ID=45855775

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010183A MX340574B (es) 2011-03-17 2012-03-14 Imidazo pirazinas.

Country Status (11)

Country Link
US (1) US8673905B2 (es)
EP (1) EP2686319B1 (es)
JP (1) JP5796094B2 (es)
KR (1) KR101561756B1 (es)
CN (1) CN103429593B (es)
BR (1) BR112013019160A2 (es)
CA (1) CA2830131A1 (es)
ES (1) ES2590928T3 (es)
MX (1) MX340574B (es)
RU (1) RU2600327C2 (es)
WO (1) WO2012123470A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9653770B2 (en) 2014-10-21 2017-05-16 At&T Intellectual Property I, L.P. Guided wave coupler, coupling module and methods for use therewith
US9586949B2 (en) 2015-02-09 2017-03-07 Incyte Corporation Aza-heteroaryl compounds as PI3K-gamma inhibitors
SMT202200250T1 (it) 2015-11-06 2022-07-21 Incyte Corp Composti eterociclici come inibitori della pi3k-gamma
AR107293A1 (es) 2016-01-05 2018-04-18 Incyte Corp COMPUESTOS DE PIRIDINA Y PIRIDIMINA COMO INHIBIDORES DE PI3K-g
WO2017223414A1 (en) 2016-06-24 2017-12-28 Incyte Corporation HETEROCYCLIC COMPOUNDS AS PI3K-γ INHIBITORS
WO2018191476A1 (en) * 2017-04-12 2018-10-18 Magenta Therapeutics, Inc. Aryl hydrocarbon receptor antagonists and uses thereof
RS62818B1 (sr) 2017-10-18 2022-02-28 Incyte Corp Kondenzovani derivati imidazola zamenjeni tercijarnim hidroksi grupama kao inhibitorima pi3k-gamma
SG11202006832YA (en) 2018-01-29 2020-08-28 Merck Patent Gmbh Gcn2 inhibitors and uses thereof
KR20200116481A (ko) * 2018-01-29 2020-10-12 메르크 파텐트 게엠베하 Gcn2 억제제 및 이의 용도
CR20250050A (es) 2018-09-05 2025-03-19 Incyte Corp Formas cristalinas de un inhibidor de fosfoinositida 3–quinasa (pi3k) (divisional 2021-0165)
JP2022539849A (ja) * 2019-07-10 2022-09-13 オーセントラ セラピュティクス ピーティーワイ エルティーディー 治療薬としての４－（イミダゾ［１，２－ａ］ピリジン－３－イル）－Ｎ－（ピリジニル）ピリミジン－２－アミンの誘導体
CN111646978B (zh) * 2020-06-11 2021-12-21 浙江大学 N2-取代烷氧芳环-2-氨基嘧啶类衍生物及应用
MX2023006938A (es) * 2020-12-23 2023-10-13 Childrens Hospital Med Ct Compuestos inhibidores multicíclicos de la cinasa asociada al receptor de interleucina-1 (irak) y la tirosina cinasa 3 similar a fms (flt3) y usos de estos.
EP4377315A4 (en) * 2021-07-30 2026-01-28 Childrens Hospital Med Ct Multicyclic compounds that inhibit Iraq and FLT3, and their uses

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7186832B2 (en) 2003-02-20 2007-03-06 Sugen Inc. Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors
WO2006025567A1 (ja) 2004-08-31 2006-03-09 Banyu Pharmaceutical Co., Ltd. 新規置換イミダゾール誘導体
US20070055743A1 (en) 2005-09-02 2007-03-08 Pirtle Ross M Remote control media player
TW200800213A (en) * 2005-09-02 2008-01-01 Abbott Lab Novel imidazo based heterocycles
US7683060B2 (en) * 2006-08-07 2010-03-23 Incyte Corporation Triazolotriazines as kinase inhibitors
CA2665384A1 (en) 2006-10-16 2008-04-24 Gpc Biotech Inc. Pyrido [2, 3-d] pyrimidines and their use as kinase inhibitors
CN101589045A (zh) * 2006-11-08 2009-11-25 先灵公司 作为蛋白质激酶抑制剂的咪唑并吡嗪
UY30892A1 (es) 2007-02-07 2008-09-02 Smithkline Beckman Corp Inhibidores de la actividad akt
WO2008156614A2 (en) * 2007-06-14 2008-12-24 Schering Corporation Imidazopyrazines as protein kinase inhibitors
TW200938542A (en) * 2008-02-01 2009-09-16 Irm Llc Compounds and compositions as kinase inhibitors
ES2548135T3 (es) * 2008-05-13 2015-10-14 Novartis Ag Heterociclos condensados que contienen nitrógeno y composiciones de los mismos como inhibidores de quinasa

Also Published As

Publication number Publication date
JP5796094B2 (ja) 2015-10-21
MX2013010183A (es) 2013-10-03
CA2830131A1 (en) 2012-09-20
HK1187614A1 (zh) 2014-04-11
ES2590928T3 (es) 2016-11-24
RU2013142881A (ru) 2015-04-27
WO2012123470A1 (en) 2012-09-20
BR112013019160A2 (pt) 2016-10-04
KR101561756B1 (ko) 2015-10-19
EP2686319A1 (en) 2014-01-22
RU2600327C2 (ru) 2016-10-20
CN103429593B (zh) 2015-09-09
US20120238564A1 (en) 2012-09-20
KR20130133870A (ko) 2013-12-09
EP2686319B1 (en) 2016-07-13
JP2014508180A (ja) 2014-04-03
US8673905B2 (en) 2014-03-18
CN103429593A (zh) 2013-12-04

Similar Documents

Publication Publication Date Title
MX340574B (es) Imidazo pirazinas.
MX345928B (es) Composiciones terapeuticamente activas y metodos de uso de las mismas.
PH12014501542A1 (en) Substituted pyrrolidine -2- carboxamides
IN2014MN02598A (es)
JO3115B1 (ar) مركبات بيريدازينون واستخدامها كمثبطات daao
IN2015DN01119A (es)
MX2014014229A (es) Pirrolidina-2-carboxamidas sustituidas.
IN2014DN09434A (es)
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
MX2015017201A (es) Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga.
PH12014501514A1 (en) New azetidine derivatives, pharmaceutical compositions and uses thereof
CR20200286A (es) DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294)
TN2015000034A1 (en) Derivatives of azaindazole or diazaindazole type for treating pain
WO2013004995A8 (en) Pyrimidinone compounds and their use
GB201209587D0 (en) Therapeutic compounds
WO2014045162A8 (en) ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-AMINE COMPOUNDS
PH12015501609A1 (en) Phenicol antibacterials
PH12013500007A1 (en) Piperidine derivatives and their use for the treatment of metabolic disorders
TW201613864A (en) Novel compounds
PH12015501088A1 (en) Dimeric compounds
MX2012008328A (es) Derivados de pirazina.
IN2014DN09347A (es)
WO2014062838A3 (en) Pkm2 modulators and methods for their use
WO2012135615A3 (en) Enopeptins, uses thereof, and methods of synthesis thereto
MX2015007940A (es) Compuestos tricíclicos como inhibidores de cftr.

Legal Events

Date Code Title Description
FG Grant or registration